Aleafia Health Gets License Update for Edible Products

Aleafia Health (TSX:ALEF,OTCQX:ALEAF) said on Thursday (November 14) that it has obtained a critical license for its participation in the next phase of cannabis legalization in Canada, but it has not committed to a timeline for product availability.

The producer confirmed that Health Canada has approved two license amendments for the company at its facility in Paris, Ontario, allowing for the production and sale of new product formats.

Aleafia Health CEO Geoffrey Benic said the timing gives the company the ability to jumpstart production of the products, which are set to be introduced under Canada’s second stage of legalization.

Edible and infused cannabis products will become available in the country starting in mid-December as part of the federal government’s rollout plan.

Various marijuana producers have raced to make their products available on day one and to introduce consumers to their branded items.

In an email statement to the Investing News Network, Aleafia Health CFO Benjamin Ferdinand said the company had originally expected to produce its novelty products out of the second phase expansion of its Paris facility.

“However, with these license amendments, we are able to jumpstart this process, as we now have adequate, licensed processing space to produce new formats, including edibles and topicals,” he said.